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Abstract

In 2010, there were 51.4 million surgical procedures performed in the United States alone
(Centers for Disease Control, 2012). Many people have surgery at some point in their life,
whether it is an unavoidable or elective procedure. Diabetes, including blood glucose
management, must be taken into account when undergoing a surgical procedure. For the
provider, coming into contact with diabetic patients is common due to the high prevalence of the
disease. Fifty percent of diabetics will have surgery at some point in their life (Miller &
Richman, 2016, p. 155). This paper will review the case of a 67-year-old diabetic patient who is
scheduled to have a right total knee arthroplasty. An examination of the literature will help to
determine the best way to manage blood sugars and avoid complications in diabetics undergoing
surgery. Specifically identifying target blood glucose for surgical patients, and the effects of
blood glucose levels on patient outcomes. As providers it is in our patients’ best interest to
review the most recent literature and drive our policies based off of evidence based practice.
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Background

Diabetes is a prevalent condition in the United States, and one that can’t be ignored by
providers. It had a prevalence of 29.1 million of the U.S. population in the year 2012 (American
Diabetes Association, 2016). World-wide, the prevalence of diabetes is around 387 million
(Dhatariya, Levy, & Hall, 2016). This number is expected to increase to 600 million people by
the year 2035 (Dhatariya, Levy, & Hall, 2016). Due to the high number of diabetic patients who
may at some point have surgery, it will be essential to determine the best way to manage their
disease during this time of high stress.
When diabetics are under stress of any kind, blood sugars rise. Surgery is a type of stress,
that could potentially increase blood sugars. The long-term effects of high blood sugars on
patients have been well established. The research shows complications including peripheral
neuropathy, poor wound healing, increased risk of infection, increased blood pressure, and
kidney disease (Mayo Clinic, 2015). One goal in this review is to determine complications
arising from periods of hyperglycemia.
Hyperglycemia is prevalent in surgical patients due to compounding factors. Surgery is a
type of stress on the body. During this time of stress, the body has an increased release of
hormones including epinephrine, cortisol, and inflammatory mediators from activation of the
sympathetic nervous system (Evans, Lee, & Ruhlamn, 2015). This combination results in an
increase in glucose throughout the body (Evans, Lee, & Ruhlman, 2015). Patients undergoing
surgery may have periods of immobility after surgery. Immobility can cause higher blood
glucose concentrations from decreased utilization of glucose (Evans, Lee, & Ruhlman, 2015).
Medications, such as intravenous fluids containing dextrose, or steroids, may be administered
during surgery (Evans, Lee, & Ruhlman, 2015). Both of these may increase a patient’s blood

BLOOD GLUCOSE MANAGEMENT

5

sugar. Due to this described phenomenon, a literature review was completed to determine the
most effective methods to manage of diabetes in the surgical patient and prevent complications.
We will discuss the case of a 67-year-old male who is scheduled for a right knee
replacement. This patient has a 43-year history of Type I Diabetes Mellitus. He has an insulin
pump and uses 80-90 units of fast acting insulin each day, with average blood sugars around
125mg/dL. Keeping the patient’s best interest in mind, this paper will explore the literature to
determine the best way to manage his disease so that he may have the best outcome with his
surgical procedure.
Case Report
On February 5th, 2016, a 67-year-old male, who will be referred to as J.H., presented to
the clinic for a pre-operative physical for a right total knee arthroplasty. He has a history of
osteoarthritis and is scheduled for his procedure on February 28th. J.H. stated the arthritis pain
was constant in his right knee, and he rated it 5/10 on the pain scale. He reported the pain was
worse with activity and was starting to give him balance issues, although he hadn’t had any falls.
He reported when he needed to do a lot of walking he would use a cane. Moving about the house
he did not require any assistive devices. He had a left total knee arthroplasty done in December.
He reported nausea on post-op day 1 that was controlled with antiemetic medication. Otherwise,
he healed quickly and tolerated the procedure well with no complications.
His past medical history consisted of the following: type I diabetes since 1973,
hyperlipidemia, hypertension, and osteoarthritis. He denied a history of any difficulty with
anesthesia or any bleeding disorders. The medications he was taking were: Losartan 10mg daily,
Novolog insulin pump (average of 80-90 units/day), Simvastatin 80mg daily, Aspirin 81mg
daily, and Ibuprofen 3 tabs daily at night as needed for pain. His surgical history consisted of

BLOOD GLUCOSE MANAGEMENT

6

ligament repairs in both knees, left total knee arthroplasty, appendectomy, two hernia repairs,
and wrist surgeries.
J.H. was married with a supportive wife who will be there to assist him after surgery. He
was still working as a construction worker as he was able to tolerate with his knee pain. He was a
current smoker with a 30-pack-year history. He drank 1-2 cans of beer daily, with no history of
alcohol abuse. He denied recreational drug abuse.
His family history was reviewed and was significant for a brother who had a stroke at age
69. His father died at 69 due to “heart problems.” He denied any knowledge of anyone in the
family having difficulty with anesthesia, or bleeding disorders. No other heart disease in the
family, and no lung disease in the family.
For his review of systems, this patient reported feeling well despite his knee pain. He
denied any recent colds, cough, or respiratory infections. No chest pain, shortness of breath,
palpitations, or racing heart beats. He denied any history of poor wound healing, or changes to
his skin including on his feet. He does foot exams on a daily basis. He denied nausea or
vomiting. He has had constipation troubles in the past, particularly after his last arthroplasty, but
it was relieved with stool softeners. He denied any bloody, black, or tarry stools. He has had no
trouble with urination except for frequency. He denied dysuria or urgency. As stated in his
history of presenting illness, he has had some difficulty with ambulating which required
utilization of a cane. He did experience some numbness in his left leg, but stated he still had full
sensation.
On physical examination, his vitals were found to be: blood pressure of 158/94, heart rate
of 76, respiratory rate of 20, and afebrile at 98.8. His head was normocephalic, and atraumatic.
Tympanic membranes were pearly grey bilaterally with some cerumen noted in ear canals. Oral
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mucosa was pink and moist, with no lesions noted to oropharynx. No lymphadenopathy to head
or neck.
Auscultation of his heart revealed S1 and S2 of regular rate and rhythm. No murmurs,
clicks, or rubs were identified. No edema to bilateral lower extremities. His capillary refill on his
toes were less than 3 seconds. Lung sounds were clear to auscultation bilaterally. Equal
respiratory expansion, with nonlabored breathing.
Bowel sounds were normoactive. Abdomen was flat. No hepatosplenomegaly was
identified. His abdomen was nontender to palpation.
Skin inspection revealed pale lower extremities, which were warm to the touch. No open
lesions or color changes to his feet. On musculoskeletal examination, the patient was able to get
onto the exam table with relative ease, and required no assistance. Deep tendon reflexes were 3+
to the upper extremities, 1+ in the right lower extremity, and unable to assess in his left lower
extremity after two attempts. He was able to sense touch on bilateral lower extremities. His
affect was appropriate and he appeared well groomed.
His assessment for the exam with corresponding ICD-10 codes were:
1.! Pre-operative physical - Z01.81
2.! Type I Diabetes Mellitus – E10
3.! Hypertension – I10
4.! Nicotine dependence, cigarettes – F17.21
5.! Hyperlipidemia – E78.5
Recent laboratory work reviewed from surgical procedure in December. CMP, CBC,
chest x-ray, and EKG were done for this pre-operative examination. The testing revealed a blood
glucose of 96, which was within normal limits. His last A1C was drawn in November by his
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physician managing his diabetes. His kidney function was normal with a BUN of 9, and
creatinine of 0.8. His electrolytes and liver function studies were also within normal limits. His
hemoglobin and hematocrit were 12 and 34.5% respectively, which will need to be monitored by
orthopedics following surgery, but is not a concern for him going under anesthesia. His chest xray was within normal limits, showing no effusions or infiltrates. His EKG revealed he was in
sinus rhythm with a rate in the 70s.
Patient was hypertensive at 158/94. He reported he does check his blood pressure at
home 1-3 times per week and usually was in the 130s/80s. Patient requested to not make any
changes to his medication at the time. Patient will return to clinic in a couple of days to have his
blood pressure re-checked by a nurse. If his blood pressure was still elevated at that time, the
plan was to increase his Losartan to 25mg and re-check his blood pressure one week later.
Provider stressed the importance of good blood pressure control prior to going under anesthesia.
Patient instructed to follow-up with his orthopedic surgeon regarding their wish about his
Ibuprofen and Aspirin use prior to surgery. Patient instructed to quit smoking. He was to
continue managing his diabetes as he normally did. This consisted of monitoring his blood sugar
frequently throughout the day, and utilizing his pump to keep his glucose under control.
Literature Review
This section will review the current evidence regarding diabetic control in patients
undergoing surgery, as J.H. has had this disease for 43 years. A literature search was done
utilizing Pub Med, CINAHL, and Up-To-Date databases. Keywords used in the searches
included “hyperglycemia,” “diabetes,” “surgery,” “complications,” “perioperative,”
“management.” This section will review ten pieces of literature that contribute to determining
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what the consequences are of hyperglycemia, and how to best manage blood glucose levels in
these patients.
Consequences of Hyperglycemia
After a review of four studies, the most common complications from hyperglycemia were
found within the surgical wound. Infections and poor wound healing were by far the most
common complication. From those complications, surgical revisions seemed to be a common
requirement. Having a patient undergo a second surgery in itself brings additional potential
compromise. Infection was not limited to the wound however, as infection was found to be
increased throughout the body including pneumonia, and urinary tract infections.
The first study reviewed by Stryker et. al (2013), evaluated blood sugar control in
diabetics before and after total joint arthroplasty and the effects on wound healing. The initial
patient sample had a total of 1,702 patients undergoing joint replacement in the years 2004-2011.
From those, they looked specifically for anyone who had a wound complication within the next
thirty days; specifically, hematomas, superficial infections, delayed healing, necrosis, or
dehiscence of the wound.
Of those 1,702 patients, 237 were found to have wound complications in the thirty days
following surgery. Exclusions for the study were made, including those who didn’t have at least
48 hours of inpatient post-operative glucose levels available. This left a total of 41 patients. The
study then matched a control group accounting for age, sex, procedure, approach, tourniquet use,
and bone cement with and without antibiotic impregnation. After the control group was matched,
a total of thirty patients were used for the study.
The group consists of twenty-two total knee arthroplasty patients, seven total hip
arthroplasty patients, and a shoulder arthroplasty patient. What they found was patients with a
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glucose level above 200 after surgery were at a higher risk of wound complications (Stryker et.
al, 2013). They also correlated hemoglobin A1C greater than 6.7% to have a significant
association with complications in the thirty days following the surgical procedure (Stryker et. al,
2013). The most common complication being delayed wound healing, drainage, contained and
draining hematomas, and superficial infections (Stryker et. al, 2013). From this study, they allow
you to make the conclusion that better glucose control leads to decreased complications.
However, this ended up being a small study of only thirty patients.
A retrospective study done in 2011 reviewed 55,408 patients with diabetes who had noncardiac surgeries between the years 1999-2004. Relating to our case at hand, 2,496 patients were
having total knee arthroplasties (King, Goulet, Perkal, & Rosenthal, 2011). These patients were
part of the Veterans Affairs patient population in the Connecticut Healthcare System. Fifty-one
percent of all patients had pre-operative blood glucose levels greater than 150 mg/dL. Of those
patients with pre-operative hyperglycemia, 72% had post-operative blood glucose levels greater
than 150 mg/dL (King, Goulet, Perkal, & Rosenthal, 2011). That percentage is high, making the
outcomes for those patients more intriguing.
Infections developed in eight percent of that population. The highest offender was
superficial skin infections, followed by urinary tract infections, pneumonia, deep skin infections,
and sepsis (King, Goulet, Perkal, & Rosenthal, 2011). There wasn’t a statistical significance
found between blood glucose levels maintained between 111-149 mg/dL and infection rates.
Those with the highest rates of infections were noted to have post-operative glucose levels of
150-250 mg/dL (King, Goulet, Perkal, & Rosenthal, 2011). This study did not find that the preoperative glucose levels and the hemoglobin A1C to have effects on infection rates (King,
Goulet, Perkal, & Rosenthal, 2011). Interestingly, a 10.3% increase in perioperative rates were
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found in those with glucose levels less than 80 mg/dL (King, Goulet, Perkal, & Rosenthal, 2011).
Those in the blood glucose range of 80-110 mg/dL had the least amount of post-op infections at
6.7%, followed by those with blood glucose levels maintained at 111-149 had a 7% rate of
infection (King, Goulet, Perkal, & Rosenthal, 2011). This leads to a conclusion of better glucose
control also leading to fewer complications, although hemoglobin A1C was not found to be a
factor here as it was in the previous study.
The study did have drawbacks, as it was predominately white (67% of the population)
males (97% of the population). These patients did have other risk factors that were taken into
account such as age, cigarette smoking, alcohol abuse, steroid use within thirty days of surgery,
cancer, radiation therapy and chemotherapy (King, Goulet, Perkal, & Rosenthal, 2011). It’s
important this bias was addressed to not skew the results of the study.
A separate study by Watts et. al, (2016) was done to review the outcomes of insulindependent diabetics (IDD) who underwent a total knee joint arthroplasty. They compared the
results to non-diabetics, and type II diabetics who were not insulin-dependent. The study
included 17 years of data from one facility, with a total of 1,284 in the non-diabetic group, 530 in
the diabetic group, and 164 in the insulin-dependent diabetic group. All of these patients were
classified as morbidly obese with a BMI > 40. They excluded type I diabetics for the study.
They found that the insulin-dependent diabetics had higher rates of prosthetic joint
infections, surgical revisions, and re-operation requirements compared to the diabetic and nondiabetic group. (Watts et. al, 2016). From the insulin-dependent patients, those requiring surgical
revision were mostly under the age of 65. Twenty percent of the IDD patients required reoperation, compared to only twelve percent of both the diabetic group and non-diabetic group
(Watts et. al, 2016). Infection rates were found in eight percent of the IDD group, compared to
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four percent in both the non-diabetic group and diabetic group (Watts et. al, 2016). Overall,
survivor rates were lowest in the insulin-dependent group (Watts et. al, 2016). The take-away
message here is those who depend on insulin to control their diabetes had more complications.
The next analysis looked at a retrospective cohort study which examined glucose control
in surgical patients in the state of Washington. It evaluated the outcome of insulin administration
to patients with hyperglycemia, with or without a diagnosis of diabetes, prior to having elective
colorectal or bariatric surgery. The study spanned over a five-year period in 47 different
institutions, and a total of 11,633 patients. The level of hyperglycemia was defined as anything
over 180 mg/dL. The authors found the effects of hyperglycemia on surgical patients to be
significant. Patients experienced a two-fold increased risk of infections, increased in-hospital
mortality, and increased requirement of re-operative interventions (Kwon et. al, 2013). The study
also determined that for every 10-unit increase in blood glucose level, there was a seven percent
increase in the patient’s odds of contracting an infection (Kwon et. al, 2013). The highest odds of
infection found in those who were hyperglycemic on post-op days 1-3, compared to those who
were hyperglycemic just on the day of surgery (Kwon et. al, 2013). This compounds on the
previous information that good glucose control is imperative to decrease post-operative
complications.
From this review, it’s clear that maintaining patient’s glucose levels in the range of 110180mg/dL is imperative to prevent the numerous complications outlined above. Keeping tight
control of levels below 110 mg/dL didn’t draw a benefit in any of the studies reviewed.
Management of Blood Glucose Levels
From the review of literature, blood glucose levels should be maintained between 110180mg/dL for the best outcomes in the patient. Diligent glucose monitoring should be
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performed, starting before surgery, continuing during surgery, and throughout the hospital stay.
Patients glucose levels are better controlled with an insulin regimen. This could be either
maintaining use of an existing insulin pump, or a basal and bolus regimen which more closely
mimics the insulin release in a non-diabetic patient. With use of insulin, watching for episodes of
hypoglycemia is important, which is another important reason for close monitoring. Evaluating
A1C prior to surgery had mixed reviews in terms of usefulness. Generally, if the patient’s
glucose levels are extremely elevated, or the patient is in ketoacidosis, surgery should be
postponed if possible. Using a standard plan of care that is followed for every patient is
encouraged.
J.H. was a type I diabetic with an insulin pump. As he readies for surgery, the literature
supports continuing insulin during surgery, perhaps even using his pump. Reviewing an article
from the Current Diabetes Report by Thompson et. al (2016) stated there were no current
standards in perioperative care regarding insulin pump use, but research had been ongoing. This
article supported the use of incorporating care process models (CPM), which was a protocol used
for patients undergoing elective surgery under general anesthesia. The general guideline of this
protocol included treating patients with insulin if their blood glucose rose over 140 mg/dL.
Blood glucose was checked prior to surgery, during surgery, and in the post-anesthesia care unit
(PACU). If the surgical procedure was longer than 60 minutes, the patient’s blood glucose was
monitored hourly. By incorporating a CPM, glucose monitoring in the perioperative period in
diabetics were increased, as well as increased insulin administration in those with glucose levels
above 140mg/dL (Thompson et. al, 2016). Over a 12-month period of utilizing this CPM, they
were found to have lower blood glucose levers in the pre-operative period, and in the PACU,
with no increase in hypoglycemic events (Thompson et. al, 2016). This suggested if facilities
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utilized protocols, there would be improvement of glucose monitoring, allowing for quicker
recognition of hypo or hyperglycemia. More studies should be done regarding the safety of using
patient’s insulin pumps, but this information was promising.
Another study looked at the comparison of using a sliding scale insulin (SSI) regimen,
versus a basal/bolus insulin regimen for surgical patients. Many facilities have turned towards
discontinuing patients home diabetic agents when they’re admitted to the hospital, and using SSI
instead (Umpierrez et. al, 2011). However, successful results from the use of SSI were lacking
(Umpierrez et. al, 2011). The goal of therapy in this study was to maintain fasting and pre-meal
glucose levels between 100-140 mg/dL. The study concluded that better glycemic control was
maintained when the patient was administered a basal/bolus insulin regimen, instead of the SSI
(Umpierrez et. al, 2011). Twelve percent of the patients held blood sugars over 240 mg/dL
despite increasing the SSI to the maximum scale (Umpierrez et. al, 2011). Those on SSI
incidentally were also found to have higher wound infection rates (30.8% vs 7.5%) (Umpierrez
et. al, 2011). This concludes that switching the patient over to a basal/bolus treatment regimen
will result in better glucose control, which could result in decreased complications.
An observational study by Frisch et. al (2010), was done on general surgery patients in a
Georgia hospital over a 6-month time span. After excluding patients with multiple admissions,
and those over the age of 90, they reviewed 3,184 patients. Six-hundred-forty-three of those
patients were known diabetics. Non-diabetic patients had lower blood sugars on the day of
surgery, as you would suspect, with an average of 113 mg/dL. Diabetic patients had an average
blood glucose of 145 mg/dL on the day of surgery. The day following surgery, diabetic averages
were 155 mg/dL, compared to 132 mg/dL in non-diabetics (Frisch et. al, 2010). Forty percent of
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the total number of patients had blood glucose levels above 140 mg/dL. Of that group, 75% of
those patients maintained blood sugars between 141-180 mg/dL (Frisch et. al, 2010).
The researchers found that those who were non-diabetic with hyperglycemia during the
perioperative phase had higher levels of mortality (Frisch et. al, 2010). Hyperglycemic patients
also had higher rates of pneumonia, urinary tract infections, skin infections, and acute renal
failure (Frisch et. al, 2010). These complications aren’t to be made light of, and could pose
significant threats to patients. This also draws attention to the fact that even if patients don’t have
diabetes, hyperglycemia can lead to poor outcomes.
An article by Evans, Lee, & Ruhlman (2015) reviewed glucose management in surgical
patient, and recommended a goal blood glucose of 140-180mg/dL. Through their examination of
the research, there were higher episodes of adverse effects with hypoglycemia with tighter
glucose control of 80-110 mg/dL, and little to no benefit of having such tight control (Evans,
Lee, & Ruhlman, 2015). The hypoglycemic levels had poor outcomes especially in the pediatric
and traumatic brain injury patients (Evans, Lee, & Ruhlman, 2015). They also recommend
intravenous insulin therapy versus subcutaneous insulin therapy in the following cases: type 1
diabetics who are NPO, any patient during the perioperative period, or in labor having a baby,
any patient in ICU with glucose levels over 180mg/dL, poorly controlled glucose ranges with
subcutaneous insulin therapy, any cardiac surgery patient, post myocardial infarction patients
with levels greater than 180mg/dL, and those presenting with diabetic ketoacidosis (Evans, Lee,
& Ruhlman, 2015, p. 349). They found no data to support using intravenous therapy in noncritically ill patients, so other patients who do not fall into the above categories may be treated
with subcutaneous insulin (Evans, Lee, & Ruhlman, 2015). This evidence supports not having
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“over-control” of glucose levels. For our patient at hand, possibly the use of intravenous insulin
for better control.
Looking at another article reviewing management of diabetic patients undergoing surgery
by Miller & Richman (2016) provided a different set of guidelines. In contrast to one of the
previous studies reviewed, this article did correlate findings of A1C greater than nine percent
with associated complications (Miller & Richman, 2016). They recommended consideration of
delaying surgery for those patients (Miller & Richman, 2016). They also recommended delaying
surgery for patients in diabetic ketoacidosis (Miller & Richman, 2016). They recommended
scheduling diabetics as the first surgical cases of the day if possible, as it may allow decreased
interference with the patient’s regular blood glucose management depending on the length of
procedure (Miller & Richman, 2016). Blood glucose checks should be done in the holding area
before surgery to detect hypo or hyperglycemia, and treated as needed with either dextrose IV
fluids or insulin (Miller & Richman, 2016). If glucose levels were stable, they should be checked
hourly during surgery, or more frequently if their glucose had been unstable (Miller & Richman,
2016).
Pertaining to this patient case with an insulin pump, Miller and Richman (2016),
recommend consulting endocrinology prior to surgery on those wishing to use their insulin pump
during surgery. Most procedures may allow patients to continue to use their pump with prior
guidance from the endocrinologist. However, those who are having cardiac surgery, open
abdominal surgeries, or vascular surgery should be switched to intravenous therapy instead
(Miller & Richman, 2016). The site of the pump should be moved away from the site of surgery
(Miller & Richman, 2016). Per this study, J.H. would qualify for use of his insulin pump versus
switching to intravenous therapy.
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A study by Nair, Horibe, Neradilek, Newman & Peterson, (2016) examined the effects of
managing glucose levels during surgery and the outcomes of glucose in the post-operative
period. It was a retrospective cohort study of 2,440 non-cardiac surgical patients from 20112013. These patients were either diagnosed with diabetes, or had glucose levels greater than
140mg/dL during surgery. They compared a group that had insulin initiated when glucose levels
reached 140mg/dL, and a group that had insulin started once they reached 180mg/dL. Overall
they found that if they started giving the patients insulin when their glucose reached levels above
140mg/dL during surgery, around 59% of the patients had hyperglycemia in the first 24 hours
post-operatively (Nair, Horibe, Neradilek, Newman, & Peterson, 2016). That number is
compared to the 70% of the 180mg/dL group of patients that experienced 24-hour hyperglycemia
(Nair, Horibe, Neradilek, Newman, & Peterson, 2016). They experienced hypoglycemia levels in
both groups. The 140mg/dL group had a 1.8% post-operative hypoglycemia rate, and the
180mg/dL group had a 2.2% rate, with conclusions of no statistical difference between the two
groups (Nair, Horibe, Neradilek, Newman, & Peterson, 2016).
This study recommended instituting intra-operative insulin for patients when their blood
glucose went above 140mg/dL to decrease the risks of being hyperglycemic in the post-operative
period (Nair, Horibe, Neradilek, Newman, & Peterson, 2016). Recommendations included
watching carefully for hypoglycemia, especially in the post-operative period, and continuous
monitoring of the patient (Nair, Horibe, Neradilek, Newman, & Peterson, 2016).
This review provides evidence to assist with managing diabetic surgical patients. It
makes sense to monitor blood sugars closely, looking for hyper or hypoglycemia, especially
while the patient is under anesthesia. Implementing a facility protocol may assist with improving
scheduled monitoring of glucose levels. By doing this, catching episodes of hypo or
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hyperglycemia may occur more quickly than without a protocol requiring diligent monitoring.
As the evidence suggests, preventing these extreme alterations of normal will improve patient
outcome. Insulin, which may have a “bad” connotation to many patients, may improve outcomes
for patients. Using insulin versus a pill allows a greater capability to fine-tune glucose levels.
This information also had some suggestions to monitor glucose levels of all surgical patients,
having higher mortality rates in non-diabetics with hyperglycemia.
Providers are equipped with the ability to manage these patients, and have the evidence to
back these decisions. Implementing change into practice is the next step. With the mountain of
evidence regarding the importance of the outcome to the patient, implementation into practice
should be done in timely fashion.
Learning Points
•! Diabetics have special considerations for surgery. Even those who are not diagnosed with
diabetes but have a high blood sugar preoperatively, may require special considerations
to avoid complications post-operatively
•! Glycemic target for surgical patients is most consistently reported between 110-180
mg/dL
•! Blood sugars should be monitored before, during, and after surgery, and throughout the
hospital stay for diabetics
•! Keeping blood glucose levels under 180mg/dL has shown improved patient outcomes
avoiding complications such as skin infections, pneumonia, sepsis, urinary tract
infections, longer hospital stays, repeat surgical interventions, and overall mortality
•! Practitioners should determine if switching to a basal/bolus insulin regimen instead of a
sliding-scale protocol during a time of acute stress would benefit the patient, as well as
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consider use of intravenous insulin therapy if it’s appropriate. Some patients may be able
to use their insulin pump during surgery with consideration and consultation from an
endocrinologist
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